Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank27
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P27
Within normal range
vs 5Y Ago
-3.2x
Contraction
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
2025-42.40%-500.3%
2024-7.06%+86.0%
2023-50.53%-109.8%
2022-24.09%-21.7%
2021-19.79%-248.4%
202013.33%+123.4%
2019-56.99%+52.9%
2018-120.99%-282.8%
2017-31.60%-133.8%
2016-13.51%-